Evaluation of potential prevalence of onconeural antibodies in women with breast cancer.

Q3 Medicine
Patrycja Krolewska-Daszczynska, Marta Smycz-Kubanska, Celina Kruszniewska-Rajs, Jacek Kabut, Paweł Olczyk, Joanna Gola, Aleksandra Mielczarek-Palacz
{"title":"Evaluation of potential prevalence of onconeural antibodies in women with breast cancer.","authors":"Patrycja Krolewska-Daszczynska, Marta Smycz-Kubanska, Celina Kruszniewska-Rajs, Jacek Kabut, Paweł Olczyk, Joanna Gola, Aleksandra Mielczarek-Palacz","doi":"10.36740/Merkur202401101","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Aim: To analyse onconeural antibodies in the blood serum of breast cancer patients without neurological symptoms..</p><p><strong>Patients and methods: </strong>Materials and Methods: The study included 48 women with breast cancer. Paraneoplastic Neurologic Syndromes 12 Ag (IgG) Euroline by EUROIMMUN test was used to determine onconeural antibodies: anti-Hu, anti-Yo, anti-Ri, anti-CV2, anti-Ma/anti-Ta, anti-amphiphysin, anti-recoverin, anti-SOX1, anti-tytin, anti-zic4, anti-GAD65 and anti-Tr (DNER).</p><p><strong>Results: </strong>Results: The conducted analysis revealed the presence of onconeural antibodies such as: anti-recoverin, anti-CV2, anti-Zic4, anti-SOX1, anti-MA2/Ta and antititin in blood serum of women with breast cancer.</p><p><strong>Conclusion: </strong>Conclusions: Further analysis may allow the assessment of the possible clinical usefulness of these determinations.</p>","PeriodicalId":39518,"journal":{"name":"Polski Merkuriusz Lekarski","volume":"52 1","pages":"5-9"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polski Merkuriusz Lekarski","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36740/Merkur202401101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Aim: To analyse onconeural antibodies in the blood serum of breast cancer patients without neurological symptoms..

Patients and methods: Materials and Methods: The study included 48 women with breast cancer. Paraneoplastic Neurologic Syndromes 12 Ag (IgG) Euroline by EUROIMMUN test was used to determine onconeural antibodies: anti-Hu, anti-Yo, anti-Ri, anti-CV2, anti-Ma/anti-Ta, anti-amphiphysin, anti-recoverin, anti-SOX1, anti-tytin, anti-zic4, anti-GAD65 and anti-Tr (DNER).

Results: Results: The conducted analysis revealed the presence of onconeural antibodies such as: anti-recoverin, anti-CV2, anti-Zic4, anti-SOX1, anti-MA2/Ta and antititin in blood serum of women with breast cancer.

Conclusion: Conclusions: Further analysis may allow the assessment of the possible clinical usefulness of these determinations.

评估乳腺癌女性患者体内肿瘤细胞抗体的潜在流行率。
目的:分析无神经症状的乳腺癌患者血清中的肿瘤细胞抗体:目的:分析无神经系统症状的乳腺癌患者血清中的肿瘤抗体:材料与方法研究对象包括 48 名乳腺癌女性患者。采用EUROIMMUN测试法检测肿瘤神经综合征12Ag(IgG)Euroline,以确定肿瘤神经抗体:抗-Hu、抗-Yo、抗-Ri、抗-CV2、抗-Ma/抗-Ta、抗-phiphysin、抗-recoverin、抗-SOX1、抗-tytin、抗-zic4、抗-GAD65和抗-Tr(DNER):结果:结果:分析结果显示,乳腺癌女性患者血清中存在抗复原素、抗CV2、抗Zic4、抗SOX1、抗MA2/Ta和抗酪蛋白抗体:结论通过进一步分析,可以评估这些检测结果的临床实用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Polski Merkuriusz Lekarski
Polski Merkuriusz Lekarski Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
84
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信